Bcl-x(L) overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1109-1115

  Ibrado, Ana Maria ^a   Liu, Linda ^a   Bhalla, Kapil ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GELDANAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN BCL 2; RAF PROTEIN; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; BENZOQUINONE DERIVATIVE; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CYSTEINE PROTEINASE; HYBRID PROTEIN; MACROCYCLIC LACTAM; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL X; PROTEIN SERINE THREONINE KINASE; QUINONE DERIVATIVE; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVATION; ETIOLOGY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; BIOSYNTHESIS; CELL CYCLE; CELL STRAIN HL 60; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BENZOQUINONES; CASPASE 3; CASPASES; CELL CYCLE; CYSTEINE ENDOPEPTIDASES; HL-60 CELLS; HUMANS; LACTAMS, MACROCYCLIC; NEOPLASM PROTEINS; PACLITAXEL; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; QUINONES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0030615086     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Manfredi, J. J., and Horwitz, S. B. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther., 25: 83-125, 1984
2. Rowinsky, E. K., Onetto, N., Canetta, R. M., and Arbuck, S. G. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin. Oncol., 19: 646-662, 1992.
3. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C. Q., Mahoney, M. E., and Huang, Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore), 7: 563-568, 1993.
4. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
5. Nicholson, D. W., Alo, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, Y., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
6. Martin, S. J., and Green, D. R. Protease activation during apoptosis: death by a thousand cuts? Cell, 82: 349-352, 1995.
7. Gagliardini, V., Fernandez, P. A., Lee, R. K. K., Drexler, H. C. A., Rotello, R. J., Fishman, M. C., and Yuan, J. Prevention of vertebrate neuronal death by the crmA gene. Science (Washington DC), 263: 826-828, 1994.
8. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, S., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
9. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
10. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88: 386-401, 1996.
11. Boise, L., Gonzalez-Garcia, M., Postema, C., Ding, L., Lindsten, T., Turka, L., Mao, X., Nuñez, G., and Thompson, C. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597, 1993.
12. González-García, M., García, I., Ding, L., O'Shea, S., Boise, L. H., Thompson, C. B., and Nuñez, G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA, 92: 4304-4308, 1995.
13. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintáns, J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not Bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7350-7354, 1994.
14. L can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
15. Tang, C., Willingham, M. C., Reed, J. C., Miyashita, T., Ray, S., Ponnathpur, V., Huang, Y., Mahoney, M. E., Bullock, G., and Bhalla, K. High levels of p26Bcl-2 oncoprotein retard Taxol-induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore), 8: 1960-1969, 1994.
16. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth & Differ., 7: 1087-1094, 1996.
17. Oltval, Z. N., Milliman, C., and Korsmeyer, S. Bcl-2 heterodimerized in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
18. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Huffman, B., and Liebermann, D. Immediate early up-regulation of bax expression of p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene, 9: 1791-1798, 1994.
19. Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
20. Haldar, S., Jena, N., and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
21. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
22. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res., 54: 5501-5507, 1994.
23. Krajewski, S., Blomqvist. C., Franssila, K., Krajewska, M, Wasenius, V. M., Niskanen, E., Nordling, S., and Reed, J. C. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55: 4471-4478, 1995.
24. Rice, W. G., Hillyer, C. D., Harten, B., Schaeffer, C. A., Dorminy, M., Lackey, D. A., III, Kirsten, E., Mendeleyev, J., Buki, K. G., Hakam, A., and Kun, E. Induction of endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA, 89: 7703-7707, 1992.
25. Ray, S., Ponnathpur, V. Huang, Y., Tang, C., Mahoney, M. E., Ibrado, A. M., Bullock, G., and Bhalla, K. 1-β-D-Arabinofuranosylcytosine-, mitoxantrone- and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother. Pharmacol., 34: 365-371, 1994.
26. Hockenbery, D. Defining apoptosis. Am. J. Pathol., 146: 16-19, 1995.
27. L and Bcl-2, displaces Bax and promotes cell death. Cell, 50: 285-291, 1995.
28. Seto, M., Jaeger, U., Hockett, R. D., Graninger, W., Bennett, S., Goldman, P., and Korsmeyer, S. J. Alternative promoters and exons, somatic mutation and deregulation of me Bcl-2-lg fusion gene in lymphoma. EMBO J., 7: 123-131, 1988.
29. Lømo, J., Smeland, E. B., Krajewski, S., Reed, J. C., and Kiil Blomhoff, H. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res., 56: 40-43, 1996.
30. WAF1 and p53 requires c-raf-1. Cancer Res., 55: 4623-4626, 1995.
31. Wang, H-G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., III, Troppmair, J., Rapp, U. R., and Reed, J. C. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene, 9: 2751-2756, 1994.
32. Wang, H-G., Takayama, S., Rapp, U. R., and Reed, J. C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA, 93: 7063-7068, 1996.
33. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
34. Prokocimer, M., and Rotter, V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84: 2391-2411, 1994.
35. Hawkins, D. S., Demers, G. W., and Galloway, D. A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res., 56: 892-898, 1996.
36. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, E. Y. F., Foster, S. A., Demers, G. W., and Galloway, D. A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
37. Zha, H., Aimé-Sempé, C., Sato. T., and Reed, J. C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem., 277: 7440-7444, 1996.
38. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D., and Barr, P. J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
39. L. Nature (Lond.), 379: 554-556, 1996.
40. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., 271: 4573-4576, 1996.
41. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157, 1996.